1. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV;Darby;Blood,2007
2. World Federation of Hemophilia. Guidelines for the Management of Hemophilia. http://www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/Guidelines_Mng_Hemophilia.pdf; 2005.
3. Association of Hemophilia Clinic Directors of Canada. Clinical Practice Guidelines. Hemophilia and von Willebrand’s disease: 1. Diagnosis, comprehensive care and assessment (Edition 2, Update 2 [1999-07-07]). http://www.ahcdc.ca/vwdcare.html; 1999.
4. Association of Hemophilia Clinic Directors of Canada. Clinical Practice Guidelines. Hemophilia and von Willebrand’s disease: 2. Management (Edition 2, Update 2 [1999-07-07]). http://www.ahcdc.ca/vwd-management.html; 1999.
5. The Inhibitor Subcommittee of the Association of Hemophilia Clinic Directors of Canada. A guide to the management of patients with inhibitors to factor VIII and factor IX. ; 2010.